Copyright: ©Author(s) 2026.
World J Gastroenterol. Dec 21, 2026; 32(47): 122668
Published online Dec 21, 2026. doi: 10.3748/wjg.122668
Published online Dec 21, 2026. doi: 10.3748/wjg.122668
Figure 3 ZFP36 regulates alternative splicing of genes in AGS cells.
A: Bar plot illustrating alternative splicing events governed by ZFP36; B: Scatter plot displaying top enriched Gene Ontology biological processes among genes that undergo alternative spliced; C-E: ZFP36-mediated alternative splicing events for WWOX (A3SS), METTL2B (ES), and NEDD9 (A3SS) are presented. Left panel: Integrative genomics viewer-sashimi plot illustrating binding sites and regulated splicing events along the mRNA transcript. Upper panel displays read coverage for each regulated alternative splicing event; gene transcript structures are depicted beneath. Right panel: Structural diagrams of alternative splicing events. Bottom portion of the right panel shows confirmation via RNA sequencing and reverse transcription-quantitative polymerase chain reaction. aP < 0.05 vs negative control group, bP < 0.01 vs negative control group, dP < 0.0001 vs negative control group. NC: Negative control; OE: Overexpression; GO: Gene Ontology.
- Citation: Yu PJ, Zhu SM, Cai BJ, Ma XM, Qiao WJ, Han JJ, Zhang CW. Zfp36 zinc finger CCCH-type inhibits gastric cancer progression by upregulating lipase G and binding its 3’ untranslated region. World J Gastroenterol 2026; 32(47): 122668
- URL: https://www.wjgnet.com/1007-9327/full/v32/i47/122668.htm
- DOI: https://dx.doi.org/10.3748/wjg.122668